Immunic
IMUX
24 hedge funds and large institutions have $15M invested in Immunic in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 24 → 24 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.05% less ownership
Funds ownership: 1.54% → 1.49% (-0.05%)
15% less capital invested
Capital invested by funds: $17.6M → $15M (-$2.63M)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$379K |
| 2 |
BlackRock
New York
|
+$169K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$151K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$23.2K |
| 5 |
JP Morgan Chase
New York
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAA
Independent Advisor Alliance
Charlotte,
North Carolina
|
-$804K |
| 2 |
Millennium Management
New York
|
-$239K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$30.8K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$21.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5K |
IMUX Hedge Fund Activity: Q3 2019 in Review
24 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2019, worth a combined $15M — down 15% from $17.6M a quarter earlier.
Fund positioning in IMUX was balanced in Q3 2019: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 8 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $379K. The largest seller was Independent Advisor Alliance, exiting entirely with an estimated $804K sold.
- 24 institutional investors held Immunic (IMUX) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $15M of Immunic stock for Q3 2019, down 15% quarter-over-quarter.
- 5 funds opened new Immunic positions in Q3 2019 and 5 closed out, a net change of 0 holders.
- The largest Immunic buyer in Q3 2019 was Renaissance Technologies, an estimated $379K added.
- The largest Immunic seller in Q3 2019 was Independent Advisor Alliance, an estimated $804K sold.
Based on aggregated 13F filings for Q3 2019.